Beam Therapeutics Inc is trading 10.9% down at $29.25 today as broader market indices slide on stronger-for-longer interest rate fears.
- The decline sees the stock giving back a significant portion of its 11.13% gain recorded on June 4.
- There is no company-specific news driving the move, which aligns with a general selloff across growth and biotech sectors.
- Macroeconomic pressure is weighing on the equity market as investors react to the potential for sustained high interest rates.